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Abstract
Background: The sentinel lymph node biopsy (SLNB) was developed as a new modality in the surgical diagnosis of lymph
node metastases. Dye and radioisotope are major tracers for the detection of sentinel lymph nodes (SLN). Dye tends to
excessively infiltrate into the interstitium due to their small size (less than several nanometers), resulting in difficulties in
maintaining clear surgical fields. Radioisotopes are available in limited number of hospitals. Fluorescent nanoparticles are
good candidates for SLN tracer to solve these problems, as we can choose suitable particle size and fluorescence
wavelength of near-infrared. However, the use of nanoparticles faces safety issues, and many attempts have been
performed by giving insulating coats on nanoparticles. In addition, the preparation of the uniform insulating layer is
important to decrease variations in the quality as an SLN tracer.
Methodology/Principal Findings: We herein succeeded in coating fluorescent polystyrene nanoparticles of 40 nm with
uniform silica layer of 13 nm by the modified Sto ¨ber method. The light stability of silica coated nanoparticles was 1.3-fold
greater than noncoated nanoparticles. The popliteal lymph node could be visualized by the silica coated nanoparticles with
injection in the rat feet.
Conclusions/Significance: The silica coated nanoparticles in lymph nodes could be observed by transmission electron
microscope, suggesting that our silica coating method is useful as a SLN tracer with highly precise distribution of
nanoparticles in histological evaluation. We also demonstrated for the first time that a prolonged enhancement of SLN is
caused by the phagocytosis of fluorescent nanoparticles by both macrophages and dendritic cells.
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Introduction
The metastatic status of the sentinel lymph nodes (SLN) is
important for predicting the survival of malignancies. Since
metastatic status of the SLN is highly predictive of involvement of
the lymphatic system, the identification of SLN and biopsies are
crucial in the staging of human cancers [1–3]. A tumor-negative
SLN virtually excludes involvement of the regional lymphatics.
Sentinel lymph node biopsy (SLNB) in breast cancer surgery has
been developed to accurately assess axillary nodal status without
removing most of the axillary contents,leading toavoid unnecessary
axillary lymph node dissection in patients without axillary
involvement. In clinical research, there are two major methods
for detection of the SLN: the blue dye method and the radioisotopes
method. However, there are disadvantages with each method. The
dye method requires skill and the SLN cannot be identified without
a skin incision. Moreover, as the diameter of dye particles is too
small, it will diffuse and disappear in 15 to 20 min from the SLN,
which restrict the duration of the procedure [4]. Furthermore, if the
lymph node was embedded in fat tissue, then it may result in the
negative or negligible detection of the lymph node [5–6]. The
radioisotope method requires radioactive agents and therefore can
only be performed at a limited number of hospitals because of the
regulations for handling radioactive agents.
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nanoparticles to efficiently visualize SLN from outside the body
and determined that the appropriate size and fluorescence
wavelength in detection of SLN in animals from previous studies
[7–8].
Polymer nanoparticles incorporating fluorescent dyes have been
used for a wide variety of applications [9]. They have the potential
for use as novel biomarkers to make major advances in medical
diagnostics, targeting therapeutics, molecular biology and cell
biology as ultrasensitive tracers for multicolor labeling [10–12].
Among such applications, the long-lasting marking of SLN or
malignant lesions during the cancer surgery has a definite
advantage for the surgical treatment [13–14]. However, many
problems still remain for SLNB, such as safety, techniques to
control size of nanoparticles, ideal track time and ideal modalities
for the histological detection of sentinel node metastases.
Preparation of insulating layer with physically stable material is
an appropriate solution for some of these problems and silica is a
good candidate as such materials.
In our previous study we performed silica coating for the
100 nm particles and the silica coated nanoparticles exhibited a
more stable fluorescence to laser irradiation than the noncoated
ones [10]. We also indicated that the appropriate size for SLNB is
around 40 nm [8–9]. There have been no previous attempts to
prepare silica coated fluorescent nanoparticles of 20 and 40 nm.
Since silica coating is physically stable, it is expected to reduce the
toxicity and enable tissue processing for microscopic observation
without breakup of nanoparticles. In the present study, we
performed silica coating for fluorescent 20 and 40 nm nanopar-
ticles utilizing a seeded polymerization technique based on the
Sto ¨ber method and tried to clarify the suitability as SLN tracers by
a rat model. We also performed histological examinations of the
silica coated fluorescent nanoparticles for lymph nodes to clarify
the modality of transportation of them by transmission electron
microscopy (TEM).
Results
Formation of silica coating and concentration of TEOS
We performed the silica coating with various tetraethoxyortho-
silicate (TEOS) concentrations ranging from 0.00038 to 0.2 M.
Figure 1A and Figure 1B showed that low TEOS concentration of
0.00038 to 0.0015 M did not evoke formation of silica shell.
Figure 1C shows that a TEOS concentration of 0.009 M evoked
silica coating, but the nanoparticles aggregated. Figure 1D showed
that a TEOS concentration of 0.02 M was optimal for the silica
shell formation on 40 nm polystyrene nanoparticles, and Figure 1E
showed that a high TEOS concentration (0.2 M) caused the
formation of silica nanoclusters and silica coating could not be
formed.
The distribution of diameter was shown in Figure 2. The silica
shell thickness on 20 nm nanoparticles was 6.3+1.7 nm (Figure 2A)
while the thickness of silica shell on 40 nm nanoparticles was
13.2+2.5 nm (Figure 2B). The silica shell thickness of 40 nm
coated nanoparticles revealed a single peak while the silica coated
20 nm nanoparticles revealed two peaks in the histogram
(Figure 2C and Figure 2D). We employed silica coated 40 nm
nanoparticles for measurement of zeta potential and animal
experiments on SLN detection.
The dispersion stability of the silica coated fluorescent
nanoparticles was also measured by a zeta potential and
submicron particle size analyzer (ELS-8000, Otsuka Electronics).
The zeta potential of silica coated 40 nm nanoparticles was 22.4
mV at pH 7.2.
Figure 1. Electron microscopic images of fluorescent nanopar-
ticles with silica coating at various TEOS concentrations. (A)
Electron microscopic image of fluorescent nanoparticles and silica
formation at 0.00038 M TEOS. (B) Fluorescent nanoparticles and silica
formation at 0.0015 M TEOS. (C) Fluorescent nanoparticles and silica
formation at 0.009 M TEOS. (D) Fluorescent nanoparticles and silica
formation at 0.02 M TEOS. (E) Fluorescent nanoparticles and silica
formation at 0.2 M TEOS.
doi:10.1371/journal.pone.0013167.g001
Figure 2. Electron microscopic images and distribution of silica
thickness on fluorescent nanoparticles of 20 and 40 nm. (A)
Electron microscopic image of 20 nm fluorescent nanoparticles with
silica coating. (B) Electron microscopic image of 40 nm fluorescent
nanoparticles with silica coating. (C) Distribution of silica coating
thickness on 20 nm fluorescent nanoparticles. (D) Distribution of silica
coating thickness on 40 nm fluorescent nanoparticles.
doi:10.1371/journal.pone.0013167.g002
Silica Coated Nanoparticles
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The comparison of the fluorescence property of the 40 nm
nanoparticles before and after coating with 0.02 M TEOS is
shown in Figure 3. A spectral analysis of the silica coated
fluorescent nanoparticles exhibited no significant difference from
the original nanoparticles (data not shown).
Florescence stability of noncoated and silica coated nanoparti-
cles was estimated by continuous irradiation of laser light
(Figure 3A). Although fluorescence intensity of noncoated
nanoparticles was 3-fold higher than silica coated nanoparticles
at 0 min (Figure 3B), the light stability of silica coated
nanoparticles was 1.3-fold greater than noncoated nanoparticles
(Figure 3C, 50 min).
Fluorescent imaging of the inguinal lymph nodes in rats
The silica coated fluorescent nanoparticles were injected
subcutaneously in the feet of rats. The imaging set-up and
fluorescent images by silica coated nanoparticles are shown in
Figure 4. At 0 min and 180 min after injection, the lymphatic
systems were not observed from outside the body for both
noncoated and coated nanoparticles (Figure 5A and 5B, and
Figure 5E and 5F, respectively). As sentinel lymph nodes of the
hind extremities are usually located in inguinal and popliteal
regions, we assigned the sentinel node as an emerging fluorescence
point after stripping the skin of the inguinal and popliteal regions.
The fluorescent lymph nodes could be observed after stripping the
skin in both cases with noncoated and coated nanoparticles
(Figure 5C and Figure 5G, respectively). Macroscopic images at
180 min after skin stripping under light illumination are showed in
Figure 5D and Figure 5H for the cases with noncoated and coated
nanoparticles, respectively.
Histological analysis of the rat inguinal lymph nodes
We observed inguinal lymph nodes by TEM (Figure 6A and
Figure 6B). The inguinal lymph nodes were fixed by formalin and
histological examinations were performed. The phagocytes of
macrophages and dendritic cells were distinguished by their
morphological features. Macrophages are polyhedral free reticu-
lum cells with many pseudopods around the cell membrane.
Dendritic cells are satellite-shaped tissue-specific reticulum cells
with long radially extending processes. Figure 6A and Figure 6B
are macrophages and dendritic cells with nanoparticles injection,
respectively. The silica coated fluorescent nanoparticles were
observed to be deposited in both the macrophages and dendritic
cells by TEM (Figure 6A and Figure 6B) and fluorescence (images
not shown).
Discussion
In this study, we used the modified Sto ¨ber method to construct
the silica coating on fluorescent nanoparticles in size of 20 and
40 nm. Under the low concentration of the TEOS (0.00038 to
0.009 M), the silica layer was not formed on the polystyrene
particles. Under the optimal concentration of the TEOS at 0.02
M, the silica shells were formed and the particles did not
aggregate. The thickness of the silica layer is homogenous and well
controlled by this technique. More fine modification of TEOS
around 0.02 M may lead to fine control of the shell thickness and
diameter.
Nanoparticles for medical application should be stabilized by
modification with hydrophilic or hydrophobic molecules in order
to prevent aggregation in water or organic solvent, respectively
[15]. In our study, the concentration of TEOS of 0.00038 to 0.009
Figure 3. Fluorescence images and intensities of silica coated and noncoated nanoparticles. (A) Fluorescence image of silica coated and
noncoated nanoparticles with continuous laser irradiation. (B) Changes in the fluorescence intensity of silica coated and noncoated nanoparticles
with continuous laser irradiation. Open circles and squares show noncoated nanoparticles and silica coated nanoparticles, respectively (n=10). Error
bar, s.e.m. (C) Changes in the relative value of fluorescence intensity of silica coated and noncoated nanoparticles in (B). The mean value of
fluorescence intensity at 0 min was defined as 1. Open circles and squares show noncoated nanoparticles and silica coated nanoparticles,
respectively.
doi:10.1371/journal.pone.0013167.g003
Figure 4. Schematic of fluorescent imaging system. The
fluorescent imaging system was comprised of a laser unit, a resonant
scanner, a cylindrical lens and a charge-coupled device camera and a
computer.
doi:10.1371/journal.pone.0013167.g004
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nanoparticles and resulted in the deposition of gel-like silica
particulates around the fluorescent nanoparticles.
In clinical practice using the dye method to identify the SLN,
the incision should be made within a few minutes since the dye
moves instantaneously from the injection site to the lymphatic
system. Moreover, if the lymph vessel is damaged by skin incision
before dye moves to SLN, the lymph node will not be dyed.
Furthermore, when a prolonged time is spent for detecting the
SLN, many non-sentinel lymph nodes will also be dyed [16].
Previous studies have shown that large nanoparticles over 100 nm
were not optimal for the detection of the SLN because they require
so long period for movement to the SLN, and the ideal size was
determined to be 40 nm among 20, 40, 100 and 200 nm [8]. The
ideal SLN tracer arrives at a lymph node quickly and moves out
from the lymph node slowly. Fluorescent nanoparticles are good
candidates for such ideal tracers [17–21]. In this study, we
observed the inguinal lymph nodes from 0 to 180 min after
injection. The silica coated fluorescent nanoparticles moved to
these lymph nodes via the lymphatic network under the skin.
The durability in enhancement of the silica coated 40 nm
fluorescent nanoparticles was about 5 hr or more (data not
shown). Use of near infrared avoids autofluorescence and
improves the signal to noise ratio. The wavelength of near
infrared is ideal for fluorescence measurement of the biological
system in consideration with the autofluorescence spectrum [8].
Physical stability is an advantage of the silica coating and silica
shell protected the inner polystyrene nanoparticles in the tissue
processing for the microscopic and TEM observations. It is
important to know the impact of the material on organisms and in
vivo dynamics to realize clinical applications. Silica coated
fluorescent naonparticles could be tracked by both macroscopic
fluorescence measurement and microscopic TEM observation.
The translocation of a nanoparticle to the lymph vessels and the
Figure 5. Fluorescence images of sentinel nodes of rat lower
extremities by silica coated and noncoated nanoparticles. (A)
Fluorescence image at 0 min after injection of noncoated nanoparticles.
(B) Fluorescence image at 180 min after injection of noncoated
nanoparticles. (C) Fluorescence image at 180 min after injection of
noncoated nanoparticles with skin stripping. (D) Image at 180 min
under light illumination after injection of noncoated nanoparticles with
skin stripping. (E) Fluorescence image at 0 min after injection of silica
coated nanoparticles. (F) Fluorescence image at 180 min after injection
of silica coated nanoparticles. (G) Fluorescence image at 180 min after
injection of silica coated nanoparticles with skin stripping. (H) Image at
180 min under light illumination after injection of silica coated
nanoparticles with skin stripping.
doi:10.1371/journal.pone.0013167.g005
Figure 6. Electron microscopic images of phagocytes in
inguinal lymph nodes. (A) A macrophage in inguinal lymph nodes
with silica coated fluorescent nanoparticles injection (Black arrow head;
the outline of the macrophage, white arrow head; the silica coated
fluorescent nanoparticles). (B) A dendritic cell in inguinal lymph nodes
with silica coated fluorescent nanoparticles (Black arrow head; the
outline of the dendritic cell, white arrow head; the silica coated
fluorescent nanoparticles).
doi:10.1371/journal.pone.0013167.g006
Silica Coated Nanoparticles
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Nanoparticles of small size are directly conveyed to a lymph node
by the physical active transport of lymphatic flow. However, large-
sized nanoparticles are passively conveyed by macrophages after
phagocytosis.
The silica coated nanoparticles maintained enhancement for
several hours. Prolonged enhancement is explained by phagocy-
tosis of fluorescent nanoparticles by macrophages and dendritic
cells in lymph nodes as shown in Figure 6. There has been no
evidence identifying the cause of the prolonged enhancement of
fluorescent nanoparticles since existing fluorescent polystyrene
nanoparticles are easily broken in the process of sample
preparation for TEM. We demonstrated, for the first time, the
presence of fluorescent nanoparticles in macrophages and
dendritic cells by TEM.
Although we used near infrared based on the optical traits of the
organism to improve sensitivity, the limit for detection is less than
1 cm depth. Novel technologies are also expected for detecting
fluorescence in deep sites of organs like the acousto-optic
modulation imaging for realizing the fluorescence measurements
in the SLNB [22].
Materials and Methods
Fluorescent nanoparticles
FluoSpheresH (Invitrogen) are commercially available fluores-
cent polystyrene nanoparticles containing fluorescent molecules
within them. There are variations in the fluorescence wavelength
(515 to 755 nm) and the particle size (20 to 1000 nm). The 20 nm
and 40 nm fluorescent nanoparticles (F-8783, 2% solids and F-
8789, 5% solids), with excitation/emission wavelengths of
660 nm/680 nm, were used for this experiment.
Reagents for the Silica Coating
The chemicals of polyvinylpyrrolidone (PVP), ethanol (95.5%),
tetraethoxyorthosilicate (TEOS, 95%) and ammonia (NH4OH,
25% aqueous solution) were obtained from Wako Pure Chemical
Industries. Ultrapure deionized water (resistivity higher than 18
MV cm) was used in the preparations for the silica coating.
Silica Coating Procedures
The silica coatings of fluorescent nanoparticles were performed
in a hermetically sealed reactor equipped and the total volume of
the reactor was 30 ml. We performed silica coating by dissolving
PVP (0.3 g) in the water (5.571 ml) and then continuously agitated
the solution with a magnetic stirrer until the complete dissolution
of PVP. The PVP solution was vigorously stirred after the addition
of fluorescent polystyrene nanoparticles (0.1 ml). Ethanol was
subsequently added to the PVP/nanoparticles mixture and a pure
silica precursor TEOS was added to the PVP/nanoparticles/
ethanol mixture. We used ethanol at volumes of 23.89, 23.88,
23.80, 23.75 and 22.48 ml for the concentrations of the TEOS of
0.00038, 0.0015, 0.009, 0.02 and 0.2 M in order to find the
appropriate concentration for silica shell formation, respectively.
Ammonia (0.42 ml) was added to the PVP/nanoparticles/
ethanol/TEOS mixture, followed by the incubation of the mixture
at room temperature for 12 hr or more. The concentration of
PVP, water and ammonia of the mixture were 10 g/l, 10.9 M and
0.4 M, respectively. And the volume of the mixture was 30 ml.
The silica coated fluorescent nanoparticles were concentrated by a
rotary evaporator (NE-1, Tokyo Rikakikai) and then were rinsed
by a centrifuge (CP 70MX, Hitachi). The final volume of the silica
coated fluorescent nanoparticle suspension was 10 ml.
Electron Microscopy
The silica coated fluorescent nanoparticles suspension was
directly trickled onto the collodion membrane attachment mesh
(Nisshin EM) and images were observed using a TEM (H-7600,
Hitachi Science Systems). The TEM was operated at an 80–100
kV accelerating voltage.
Evaluation of fluorescence intensity
Fluorescence intensity of individual silica coated nanoparticles
was estimated by a specially designed fluorescence measurement
system. The system was composed of a fluorescent microscope
(IX71, Olympus), an electron multiplying charge-coupled device
camera (iXon
EM+ DU-897, Andor), a confocal unit with a Nipkow
disc (CSU10, Yokogawa) and control computing system as noted
in our previous study [23].
Preparation of the tissue sample
Tissue specimens were fixed and immobilized in 2% glutaral-
dehyde buffered with 0.1 M sodium cacodylate buffer solution
(pH 7.4). The tissue was washed with 3 changes of 0.1 M sodium
cacodylate buffer (pH 7.4) and postfixed for 120 min in a solution
of 1% OsO4 buffered with 0.1 M sodium cacodylate (pH 7.4),
then washed in three changes of deionized water and dehydrated
in 50% to 100% ethanol. Propyleneoxide was used as a
transitional solvent. The tissue was infiltrated overnight in a 1:1
mixture of Epon-Araldite and propylene oxide. On the following
day, the 1:1 mixture of Epon-Araldite and propylene oxide was
removed and replaced with 100% Epon-Araldite. The tissue
specimens were infiltrated with resin for 8 hr and polymerized for
48 hr at 60uC. The sentinel node tissue was embedded in a resin
and cut into 60 nm thin sections by ultramicrotome (Ultracut S,
Leica Microsystems). Thereafter, TEM observations were
performed.
Instrumentation for fluorescence lymph node detection
A laser scanning fluorescence imaging system consisted of a
laser unit, a resonant scanner (2K01, Optron) which resonant
frequency is 200 Hz, a cylindrical lens and a charge-coupled
device (CCD) camera (ORCA II-ER, Hamamatsu Photonics). A
diode laser (wavelength 657 nm, 56ICS153/HS, Melles Griot) was
used for excitation. The inguinal and femoral areas were
continuously scanned over an area of 30650 mm. The fluores-
cence images were observed using a CCD camera with a band-
pass filter (filter confer wavelength/680 nm, with full width at half
maximum/30 mm) (Figure 4).
Animal Experiments
Male Donryu rats, 5–7 weeks old and 150–170 g in weight
(Charles River Laboratories Japan) were used. They were
anesthetized with pentobarbital sodium (20 mg/kg) by injection
into the abdominal cavity. The hair on the lower half of the body
was shaved to avoid autofluorescence. The rats were then fixed on
a sample table in supine positions and the silica coated fluorescent
nanoparticles suspensions of 50 ml were injected in the foot pad of
the hind leg. After observation through the skin for 180 min, the
skin was stripped off and the SLN were removed. Histological
observations by TEM were performed to detect silica coated
nanoparticles in the lymph nodes.
These experiments were carried out based on the Tohoku
University guidelines for animal experiments, after permission was
granted by the Committee of Animal Use and Care of the Tohoku
University. The approval number of these experiments was
21MdA-72.
Silica Coated Nanoparticles
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